KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biogen (BIIB) Receivables - Net (2016 - 2025)

Biogen has reported Receivables - Net over the past 17 years, most recently at $1.3 billion for Q4 2025.

  • Quarterly results put Receivables - Net at $1.3 billion for Q4 2025, down 4.44% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (down 4.44% YoY), and the annual figure for FY2025 was $1.3 billion, down 4.44%.
  • Receivables - Net for Q4 2025 was $1.3 billion at Biogen, down from $1.4 billion in the prior quarter.
  • Over the last five years, Receivables - Net for BIIB hit a ceiling of $1.9 billion in Q1 2021 and a floor of $3.9 million in Q1 2025.
  • Median Receivables - Net over the past 5 years was $1.6 billion (2021), compared with a mean of $1.1 billion.
  • Biggest five-year swings in Receivables - Net: plummeted 99.55% in 2023 and later surged 8448.42% in 2025.
  • Biogen's Receivables - Net stood at $1.5 billion in 2021, then rose by 10.04% to $1.7 billion in 2022, then decreased by 2.4% to $1.7 billion in 2023, then decreased by 15.58% to $1.4 billion in 2024, then decreased by 4.44% to $1.3 billion in 2025.
  • The last three reported values for Receivables - Net were $1.3 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.6 billion (Q2 2025) per Business Quant data.